‹ All Posts
Chahat Aggrawal

4th Jun · SEBI-Registered Analyst

AstraZeneca Pharma Receives GST Order of ₹9.24 Crore

⚖️ $ASTRAZEN has received an order from the Deputy Commissioner of State Tax (Appeal) pertaining to FY2018–19, involving claims of ₹9.24 crore. The company has stated that it intends to challenge the order before the GST Appellate Tribunal.

#FundamentalViews#EquityResearch
995 likes·83 comments